ABSTRACT
Synovial sarcoma (SS) is a high-grade malignant neoplasm frequently arising in the deep soft tissue of the lower and upper extremities of young adults. Primary SS in the pelvis is extremely rare with scattered case reports. It often causes a diagnostic challenge in small biopsy and/or with aberrant expression of immunohistochemical markers. Here, we report 2 unusual cases of SS in the pelvis. Microscopically both cases present with biphasic morphology including spindle and epithelioid cells. In addition, the tumor cells in both cases expressed PAX8 and estrogen receptor. PAX8 is a transcription factor usually expressed in tumors of thyroid gland, kidney, and Müllerian system origin. The expression of PAX8 especially with co-expression of estrogen receptor can be misleading and result in a diagnosis of Müllerian tumors in female patients with pelvic masses. The diagnosis of SS for both cases was confirmed either with the fluorescence in situ hybridization or reverse transcription polymerase chain reaction showing a SS18 (SYT) (18q11) gene rearrangement. It is imperative to include SS in the differential diagnosis for malignant neoplasms exhibiting monotonous spindle cells (monophasic SS) and biphasic mixed monotonous spindle and epithelioid tumor cells in female patients with a pelvic mass. Molecular study for SS18 translocation is essential for the diagnosis in such cases.
Subject(s)
Sarcoma, Synovial , Young Adult , Humans , Female , Sarcoma, Synovial/diagnosis , Sarcoma, Synovial/genetics , Sarcoma, Synovial/pathology , Receptors, Estrogen , In Situ Hybridization, Fluorescence , Transcription Factors/genetics , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Oncogene Proteins, Fusion/genetics , PAX8 Transcription Factor/geneticsABSTRACT
OBJECTIVES: To validate the adapted Clavien-Dindo in trauma (ACDiT) tool as a novel outcome measure for patients with acute diverticulitis managed both operatively and nonoperatively. BACKGROUND: Complications following diverticulitis are difficult to classify because no traditional tools address patients managed both operatively and nonoperatively. The ACDiT grading system-graded from 0 to 5b-is applied in this manner but has not yet been validated for this patient group. METHODS: We performed a 5-year observational study of patients with acute diverticulitis at a safety-net hospital. Baseline demographics and hospitalization data were collected. ACDiT scores were assigned, and validation was undertaken by comparing scores with hospital-free days, and verifying that higher scores were associated with known risk factors for poor outcomes. Inverse probability weighted propensity scores were assigned for surgical management, and inverse probability weighted regression analysis was used to determine factors associated with ACDiT ≥ grade 2. RESULTS: Of 260 patients, 188 (72%) were managed nonoperatively. Eighty (31%) developed a complication; 73 (91%) were grades 1 to 3b. Higher grades correlated inversely with hospital-free days (rsâ=â-0.67, P < 0.0001) for all patients and for nonoperative (rsâ=â-0.63, P < 0.0001) and operative (rsâ=â-0.62, P < 0.0001) patients. Hinchey 2 to 3 and initial operative management had higher odds of having a complication of ACDiT ≥ grade 2. CONCLUSION: The ACDiT tool was successfully applied to acute diverticulitis patients managed operatively and nonoperatively, is associated with known risk factors for adverse outcomes. ACDiT may be considered a meaningful outcome measure for comparing strategies for acute diverticulitis.
Subject(s)
Diverticulitis/therapy , Outcome Assessment, Health Care , Postoperative Complications/classification , Postoperative Complications/epidemiology , Acute Disease , Adult , Cohort Studies , Diverticulitis/surgery , Female , Humans , Male , Middle Aged , Retrospective StudiesABSTRACT
OBJECTIVES: To determine the demographics, potential risk factors, endoscopic interventions and outcomes relating to gastric bezoars in pediatric patients; and comparing results with previously published literature. METHODS: Retrospective series by chart review of patients identified by International Classification of Diseases-9 codes 938 and 935, using the following Medical Subject Headings: 1, term bezoar; 2, Keywords gastric bezoar∗ or gastric foreign body∗. RESULTS: Thirty pediatric patients between ages of 2 to 18 years were found with gastric bezoars, with a female predominance. Majority had a phytobezoar. Six patients were diagnosed with dysautonomia, implying possible role of autonomic dysfunction contributing to abnormal gastric retention. Frequent symptoms included abdominal pain, nausea and vomiting, a decrease in appetite, and unintentional weight loss. A higher prevalence of underlying gastrointestinal disorders was found in those with bezoars. Nuclear medicine gastric emptying scan performed in 13 children was significantly abnormal in only 4 of these children. Most patients were treated with endoscopic removal of the bezoar. Endoscopic removal was accomplished by Roth net, generally requiring multiple passes. At follow-up, most of the children had improvement of symptoms, with bezoar recurrence in 1 patient. CONCLUSIONS: This is to our knowledge the largest series of gastric bezoars in pediatrics. On the basis of our review, phytobezoars may be under-reported in pediatrics. Bezoars should be considered in children presenting with chronic abdominal pain, nausea, and vomiting; even in developmentally normal children and those with normal gastric emptying. We suggest that dysautonomia and underlying gastrointestinal disorders may be potential risk factors.
Subject(s)
Bezoars , Adolescent , Bezoars/diagnosis , Bezoars/surgery , Child , Child, Preschool , Digestive System , Female , Gastric Emptying , Humans , Male , Retrospective Studies , Stomach/diagnostic imaging , Stomach/surgeryABSTRACT
Breast cancer is a major disease with high morbidity and mortality in women worldwide. Increased use of imaging biomarkers has been shown to add more information with clinical utility in the detection and evaluation of breast cancer. To date, numerous studies related to PET-based imaging in breast cancer have been published. Here, we review available studies on the clinical utility of different PET-based molecular imaging methods in breast cancer diagnosis, staging, distant-metastasis detection, therapeutic and prognostic prediction, and evaluation of therapeutic responses. For primary breast cancer, PET/MRI performed similarly to MRI but better than PET/CT. PET/CT and PET/MRI both have higher sensitivity than MRI in the detection of axillary and extra-axillary nodal metastases. For distant metastases, PET/CT has better performance in the detection of lung metastasis, while PET/MRI performs better in the liver and bone. Additionally, PET/CT is superior in terms of monitoring local recurrence. The progress in novel radiotracers and PET radiomics presents opportunities to reclassify tumors by combining their fine anatomical features with molecular characteristics and develop a beneficial pathway from bench to bedside to predict the treatment response and prognosis of breast cancer. However, further investigation is still needed before application of these modalities in clinical practice. In conclusion, PET-based imaging is not suitable for early-stage breast cancer, but it adds value in identifying regional nodal disease and distant metastases as an adjuvant to standard diagnostic imaging. Recent advances in imaging techniques would further widen the comprehensive and convergent applications of PET approaches in the clinical management of breast cancer.
ABSTRACT
This article discusses the application of fludeoxyglucose PET/computed tomography (CT) technology in head and neck cancer diagnosis and management, as well as advantages and disadvantages relative to traditional imaging modalities. A successful scan relies on precise patient preparation, and compliance to specific protocols before and during the scan. Finally, this article briefly introduces a PET/CT scan recently approved by the Food and Drug Administration for neuroendocrine tumors.
Subject(s)
Fluorodeoxyglucose F18 , Head and Neck Neoplasms/diagnostic imaging , Neuroendocrine Tumors/diagnostic imaging , Organometallic Compounds , Positron Emission Tomography Computed Tomography/methods , Radiopharmaceuticals , Tomography, X-Ray Computed/methods , Humans , Neuroendocrine Tumors/metabolism , Radioactive Tracers , Sensitivity and SpecificityABSTRACT
OBJECTIVES: The primary aim of our study was to evaluate gastric emptying (GE) and intestinal transit time (ITT) in children with mitochondrial disorders (MD), and secondarily to evaluate the effect of prokinetics in those with prolonged GE. METHODS: We enrolled subjects 3 to 18 years with MD and having any of the following gastrointestinal (GI) symptoms: abdominal pain, vomiting, constipation, diarrhea, or gastroesophageal reflux. Abdominal pain was scored by visual analog pain scale (1-10). Age-appropriate diet was labeled with radioactive technetium-99 sulfur colloid and its movement tracked along the GI tract. Delayed GE based on our institutional standards was defined as half emptying time >90 minutes for a solid and >60 minutes for a semisolid meal. Prolonged ITT was defined as >4 hours for the tracer to pass from mouth to cecum. A prokinetic was instituted to those with delayed GE, and the study was repeated if possible in 4 to 8 weeks. RESULTS: Of the 26 subjects, 18 (69%) had delayed GE (median GE 99 minutes) and 12 (46%) had prolonged ITT. The study was repeated in 9 subjects after administering a prokinetic for >1 month. GE normalized in only 3 subjects (median GE on treatment 128 minutes). Mean abdominal pain score, which was 4.8 (max 10) in the 9 subjects, did not improve (5.6 after prokinetic therapy). CONCLUSIONS: A high prevalence of delayed GE and prolonged ITT was seen in children with MD having GI symptoms, and these abnormalities were poorly responsive to prokinetic therapy.
Subject(s)
Abdominal Pain/etiology , Gastric Emptying , Gastrointestinal Agents/pharmacology , Gastrointestinal Transit , Gastroparesis/etiology , Mitochondria , Mitochondrial Diseases/complications , Abdominal Pain/drug therapy , Adolescent , Child , Child, Preschool , Female , Gastric Emptying/drug effects , Gastrointestinal Agents/therapeutic use , Gastrointestinal Diseases/drug therapy , Gastrointestinal Diseases/etiology , Gastrointestinal Transit/drug effects , Gastroparesis/drug therapy , Gastroparesis/epidemiology , Humans , Male , PrevalenceABSTRACT
A highly F-18 fluorodeoxyglucose-avid lung nodule was stable in both size and metabolic activity over 4 months. This was most likely nonneoplastic because a true tumor would grown in volume overtime. The high level of energy consumption was contributing functional activities or by inflammatory cells. Because the speed of tumor growth is proportional to its energy consumption, we consider the higher the metabolic activity of a lesion, the less likely of malignant if it was stable in size over time.
Subject(s)
Fluorodeoxyglucose F18 , Granuloma/diagnosis , Lung Neoplasms/diagnosis , Positron-Emission Tomography/methods , Radiopharmaceuticals , Tomography, X-Ray Computed/methods , Biopsy , Diagnosis, Differential , False Positive Reactions , Fluorodeoxyglucose F18/pharmacokinetics , Follow-Up Studies , Giant Cells, Foreign-Body/diagnostic imaging , Giant Cells, Foreign-Body/metabolism , Giant Cells, Foreign-Body/pathology , Granuloma/metabolism , Granuloma/pathology , Humans , Lung/diagnostic imaging , Lung/metabolism , Lung/pathology , Lung Diseases/diagnosis , Lung Diseases/metabolism , Lung Diseases/pathology , Male , Middle Aged , Radiopharmaceuticals/pharmacokineticsABSTRACT
BACKGROUND: It is well recognized that colorectal cancer does not frequently metastasize to bone. The aim of this retrospective study was to establish whether colorectal cancer ever bypasses other organs and metastasizes directly to bone and whether the presence of lung lesions is superior to liver as a better predictor of the likelihood and timing of bone metastasis. METHODS: We performed a retrospective analysis on patients with a clinical diagnosis of colon cancer referred for staging using whole-body 18F-FDG PET and CT or PET/CT. We combined PET and CT reports from 252 individuals with information concerning patient history, other imaging modalities, and treatments to analyze disease progression. RESULTS: No patient had isolated osseous metastasis at the time of diagnosis, and none developed isolated bone metastasis without other organ involvement during our survey period. It took significantly longer for colorectal cancer patients to develop metastasis to the lungs (23.3 months) or to bone (21.2 months) than to the liver (9.8 months). CONCLUSION: Metastasis only to bone without other organ involvement in colorectal cancer patients is extremely rare, perhaps more rare than we previously thought. Our findings suggest that resistant metastasis to the lungs predicts potential disease progression to bone in the colorectal cancer population better than liver metastasis does.
Subject(s)
Bone Neoplasms/secondary , Colonic Neoplasms/pathology , Neoplasm Metastasis , Aged , Colonic Neoplasms/diagnostic imaging , Colorectal Neoplasms/diagnostic imaging , Colorectal Neoplasms/pathology , Disease Progression , Female , Humans , Liver Neoplasms/secondary , Lung Neoplasms/secondary , Male , Middle Aged , Positron-Emission Tomography , Radiography , Retrospective Studies , Whole Body ImagingSubject(s)
Cerebral Cortex/microbiology , Fluorodeoxyglucose F18 , Spinal Canal/microbiology , Staphylococcal Infections/cerebrospinal fluid , Ventriculoperitoneal Shunt , Aged , Catheterization/adverse effects , Catheterization/instrumentation , Cerebral Cortex/diagnostic imaging , Equipment Contamination , Female , Humans , Lung Neoplasms/diagnostic imaging , Pelvis/diagnostic imaging , Peritonitis/diagnostic imaging , Peritonitis/microbiology , Positron-Emission Tomography , Radiopharmaceuticals , Scalp/diagnostic imaging , Spinal Canal/diagnostic imaging , Tomography, X-Ray ComputedABSTRACT
Inguinal herniation of the urinary bladder is not routinely seen in clinical practice. Most patients are asymptomatic and are diagnosed incidentally on diagnostic imaging or during the course of surgical repairs. Bladder herniation has previously been reported on ultrasonography and computed tomography, but not on positron emission tomography (PET) imaging. We report an interesting case of bladder herniation and describe the findings observed by PET as well as the complications associated with this abnormality.
Subject(s)
Diverticulum/complications , Diverticulum/diagnosis , Hernia, Inguinal/diagnosis , Hernia, Inguinal/etiology , Positron-Emission Tomography , Tomography, X-Ray Computed , Urinary Bladder Diseases/complications , Urinary Bladder Diseases/diagnosis , Aged, 80 and over , Humans , Male , Subtraction TechniqueABSTRACT
(18)F-Fluorodeoxy glucose (FDG) activity reflects tissue glucose metabolism; malignancies, metastases, and acute infections have relatively increased FDG activity reflecting increased glucose metabolism. Benign adrenal disease demonstrating mild FDG uptake can be worrisome for metastasis in patients with a history of malignancy. Our patient with breast and colon cancer developed gastrointestinal bleeding on heparin therapy, enlarged adrenals with heterogeneous attenuation consistent with hemorrhage and blood clots as seen on abdominal computed tomography scan, and as abnormal intense FDG activity in the bilateral adrenal glands on positron emission tomography scan.